Humira von AbbVie bekommt einen US-Konkurrenten, aber die Kosten könnten hoch bleiben | MarketScreener
![HUMIRA 40 mg/0,4 ml Injektionslösung im Fertigpen (2 St) Preisvergleich, PZN 12472566 · MediPreis.de HUMIRA 40 mg/0,4 ml Injektionslösung im Fertigpen (2 St) Preisvergleich, PZN 12472566 · MediPreis.de](https://www.medipreis.de/abbildungen/1/300/humira-40-mg-0-4-ml-injektionsloesung-im-fertigpen-2-st-orifarm-gmbh-12472566.jpg)
HUMIRA 40 mg/0,4 ml Injektionslösung im Fertigpen (2 St) Preisvergleich, PZN 12472566 · MediPreis.de
![AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd. AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd.](https://www.eisai.com/news/2018/images/news201846-1.jpg)
AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd.
![Amgen Adopts A Two-Price Strategy For The U.S.'s First Marketed Humira-Referenced Biosimilar, Amjevita Amgen Adopts A Two-Price Strategy For The U.S.'s First Marketed Humira-Referenced Biosimilar, Amjevita](https://imageio.forbes.com/specials-images/imageserve/63d9a6e23615b0bf6a3e9f12/0x0.jpg?format=jpg&width=1200)